Viewing Study NCT00082394


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2025-12-28 @ 12:03 AM
Study NCT ID: NCT00082394
Status: COMPLETED
Last Update Posted: 2017-05-24
First Post: 2004-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module